Assignee
CTXT PTY LTD
AU·15 granted patents·7 pending applications·16 citations·filing 2015–2025
Top patents by PatentIndex Score
22 records- 0190US10005792B2Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived PRMT5-inhibitorsCTXT PTY LTD·Filed 2015·Granted Jun 26, 2018·7 cites·20 claims
- 0286US10494376B2Tetrahydroisoquinoline derived PRMT5-inhibitorsCTXT PTY LTD·Filed 2015·Granted Dec 3, 2019·5 cites·22 claims
- 0380US2025092009A1Substituted condensed thiophenes as modulators of stingCTXT PTY LTD·Filed 2024·Application pending·0 cites
- 0478US10421743B2Tetrahydroisoquinolines as PRMT5 inhibitorsCTXT PTY LTD·Filed 2017·Granted Sep 24, 2019·3 cites·24 claims
- 0575US2026062393A1CompoundsCTXT PTY LTD·Filed 2025·Application pending·0 cites
- 0674US2023227423A1Substituted condensed thiophenes as modulators of stingCTXT PTY LTD·Filed 2023·Application pending·0 cites
- 0772US10519167B23-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathiesCTXT PTY LTD·Filed 2017·Granted Dec 31, 2019·1 cites·24 claims
- 0870US2024277683A1CompoundsCTXT PTY LTD·Filed 2023·Application pending·0 cites
- 0969US12365655B2CompoundsCTXT PTY LTD·Filed 2021·Granted Jul 22, 2025·0 cites·14 claims
- 1069US11028101B23-oxa-8-azabicyclo[3.2.1]octane derivatives and their use in the treatment of cancer and hemoglobinopathiesCTXT PTY LTD·Filed 2019·Granted Jun 8, 2021·0 cites·2 claims
- 1161US11911372B2CompoundsCTXT PTY LTD·Filed 2019·Granted Feb 27, 2024·0 cites·13 claims
- 1261US2020039945A1CompoundsCTXT PTY LTD·Filed 2019·Application pending·0 cites
- 1360US11613525B2Substituted condensed thiophenes as modulators of stingCTXT PTY LTD·Filed 2019·Granted Mar 28, 2023·0 cites·19 claims
- 1450US12384801B2Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of stingCTXT PTY LTD·Filed 2020·Granted Aug 12, 2025·0 cites·17 claims
- 1549US12415785B2Compound modulators of stingCTXT PTY LTD·Filed 2020·Granted Sep 16, 2025·0 cites·18 claims
- 1645US10745380B2Pyridine derivatives and their use in the treatment of cancer and hemoglobinopathiesCTXT PTY LTD·Filed 2017·Granted Aug 18, 2020·0 cites·22 claims
- 1744US10961256B2PRMT5 inhibitorsCTXT PTY LTD·Filed 2017·Granted Mar 30, 2021·0 cites·24 claims
- 1844US10787434B2Benzopiperdine derivatives and their use in the treatment of cancer and hemoglobinopathiesCTXT PTY LTD·Filed 2017·Granted Sep 29, 2020·0 cites·23 claims
- 1942US2022380354A1Benzothiophene, thienopyridine and thienopyrimidine derivatives for the modulation of stingCTXT PTY LTD·Filed 2020·Application pending·0 cites
- 2039US10647708B2Tetrahydroisoquinoline derived PRMT5-inhibitorsCTXT PTY LTD·Filed 2015·Granted May 12, 2020·0 cites·19 claims
- 2139US2021380548A1Fused [1,2,4]Thiadiazine Derivatives Which Act as KAT Inhibitors of the MYST FamilyCTXT PTY LTD·Filed 2018·Application pending·0 cites
- 2236US10550096B2Tetrahydroisoquinolines as PRMT5 inhibitorsCTXT PTY LTD·Filed 2017·Granted Feb 4, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when CTXT PTY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →